SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
vimeo.com/124121614
SISCAPA retweeted
“The biggest takeaway from my @uviccoopcareer with @SISCAPA is an appreciation for the importance & complexity of developing an accurate diagnostic test for any disease. I'll continue my research as a #UVic Honours student with Dr. Cameron this Fall.”
🔬Angela Mitchell (she/her)
SISCAPA retweeted
"I oversee the dev. of diagnostic tests for UVic-SISCAPA projects. I've known Caroline for about 10 yrs: she's an esteemed scientist & simply an outstanding person. There's no one I'd rather collaborate with."
🔬Matt Pope(he/him), @SISCAPA General Manager uvic.ca/news/academics/scien…
SISCAPA retweeted
New “gold-standard” test for COVID-19 developed by commercial-academic partnership between #UVic microbiologist Caroline Cameron and @SISCAPA thanks to @NSERC_CRSNG #COVID19 Alliance Grant.
👉ow.ly/LCBc50IMMN6
@UVicResearch @UVicScience #UnivResearch
Congratulations Dr. Cameron! It is a pleasure for SISCAPA Assay Technologies to collaborate with the Cameron Lab on this project.
uvic.ca/news/topics/2022+ope…
This new article, from Ghent University, features the use of SISCAPA technology in the development of a SARS-CoV-2 LC-MS assay!
medrxiv.org/content/10.1101/…
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
vimeo.com/124121614
Learn more about how working with @Crucial_Data has allowed @SISCAPA to seamlessly collect data for longitudinal health studies.
crucialdatasolutions.com/cas…
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
vimeo.com/124121614
The motivation for measuring inflammation is simple: inflammation is central to the understanding of human health and disease.
siscapa.com/blog/measuring-i…
SISCAPA(R) technology radically improves the sensitivity and throughput of mass spectrometry-based protein tests through specific enrichment of selected target peptides from sample digests.
siscapa.com/blog/2021/5/31/s…
SISCAPA retweeted
Did you miss our virtual panel on September 8th where we discussed a new approach for real-time continuous data collection and the future of #decentralizedtrials? Check out the on-demand recording here! crucialdatasolutions.com/vid…
View our presentation to see how frequent longitudinal sampling of biomarkers can help understand changes in health over time!
prezi.com/view/tMyNRGzAmRdMt…
Overcome the limitations of your ligand binding assay with custom #SISCAPA protein assay & panel development!
siscapa.com/customassays
SISCAPA retweeted
We hope you’ll join us at 1:00 ET on Sept. 8th for a free virtual panel as CDS’ Jeff Rogers explores a new approach for real-world, continuous data collection and how it applies to #decentralizedtrials alongside SISCAPA Assay Technologies and Merck. register.gotowebinar.com/reg…
SISCAPA retweeted
Please be sure to join us alongside one of our business partners, @SISCAPA, for a @PharmaVOICE virtual panel on September 8th at 1:00pm ET register.gotowebinar.com/reg…
SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more!
vimeo.com/124121614
SISCAPA retweeted
Waters’ latest product launch will supercharge the role of #MassSpectrometry research in the fight against #SARSCoV2. Read the blog today: bit.ly/3yC1zcS
#Covid19Research #LCMS
Introducing LongitudeDX: Understanding Changes in Health Over Time
longitudedx.com/











